U.S. Markets closed

Baron Growth Instl (BGRIX)


Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
70.59+0.30 (+0.43%)
At close: 8:00PM EDT
People also watch
FDIKXFLPKXFCNKXFKMCXAVFIX
Interactive chart
Previous Close70.29
YTD Return14.86%
Expense Ratio (net)1.05%
CategoryN/A
Morningstar Rating★★★★
Morningstar Risk Rating★★
Last Cap Gain0.00
Net Assets6.08B
Beta (3y)0.95
Yield0.00%
Holdings Turnover4.68%
Last Dividend0.00
Inception DateMay 29, 2009
Average for CategoryN/A
  • Reuters2 years ago

    Baron Growth fund adds biotechs Atara, ConforMIS to portfolio

    The $7 billion Baron Growth fund initiated positions in biotechnology firms Atara Biotherapeutics Inc and ConforMIS Inc during a sell-off in biotech companies last quarter, according to a letter to shareholders. Atara looks attractive because of its T-cell therapy that targets cancer-specific antigens, fund manager Ron Baron wrote. ConforMIS, meanwhile, uses 3D printing technology to develop custom implants for joint replacement procedures and is well-positioned to take market share, he wrote.

  • We're sorry this is all we were able to find about this topic.